HERSHBERG ROBERT sold $748K of ADPT
HERSHBERG ROBERT sold 30,664 shares of Adaptive Biotechnologies Corp (ADPT) at an average of $24.40 ($24.39–$24.41, $0.75M total) across 2 trades on 2026-08-18.
How this was made
The 30-second read
Why it matters
The insider sell reduces the director's ownership and may be interpreted as a negative signal, though the amount is modest relative to the company's market cap.
Market read
Primary disclosure of insider transaction; modest relevance for short-term traders.
What to watch
No disclosed 10b5-1 plan; the director may have personal liquidity needs.
Background
Form 4 filing by Adaptive Biotechnologies director discloses a $748K share sale.
Ticker impact
Director Robert Hershberg sold 30,664 shares for $748K, reducing his stake to 46,683 shares.
Potential short-term downward pressure on ADPT stock.
The sale size is notable for a director but not material enough to cause large price moves; traders may watch for further insider activity.
Market effects
Minimal impact on biotech sector; insider sell may be viewed as company-specific.
None
Low
Counterpoint
The sale could be unrelated to company fundamentals and merely portfolio rebalancing.
Key entities
- CompanyAdaptive Biotechnologies Corp
US-listed biotech company (ticker ADPT).
- InsiderRobert Hershberg
Director of Adaptive Biotechnologies.
